Company
Headquarters: Zibo, China
Employees: 3,393
CN¥5.65 Billion
CNY as of July 1, 2024
US$777.3 Million
| Company | Market Cap (USD) |
|---|---|
| Air Liquide SA | $101.18 B |
| Shin-Etsu Chemical Co Ltd | $79.85 B |
| Saudi Basic Industries Corp | $59.17 B |
| Air Products and Chemicals, Inc. | $56.17 B |
| BASF SE | $43.57 B |
| Company | Market Cap (USD) |
|---|---|
| Linde | $208.12 B |
| BHP | $151.21 B |
| Rio Tinto | $110.09 B |
| Air Liquide SA | $101.18 B |
| Southern Copper Corporation | $90.64 B |
Shandong Jincheng Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of III, IV Cephalosporin intermediates in the People's Republic of China. It offers characteristic bulk drugs, pharmaceutical intermediates, and fine chemicals. The company was formerly known as Shandong Jincheng Pharmaceutical Co., Ltd. and changed its name to Shandong Jincheng Pharmaceutical Group Co., Ltd in May 2017. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, the People's Republic of China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Shandong Jincheng Pharmaceutical Group Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300233 wb_incandescent